Sg3 Management, LLC Biogen Inc. Put Options Transaction History

Sg3 Management, LLC

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $4.87 Million - $5.55 Million	-19,000 Closed	0 $0
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $1.14 Million - $1.38 Million	-4,500 Reduced 23.68%	14,500 $4.02 Million
Q3 2022 May 15, 2023	BUY	$194.69 - $268.46 $876,105 - $1.21 Million	4,500 Added 31.03%	19,000 $5.07 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $5.74 Million - $7.92 Million	-29,500 Reduced 60.82%	19,000 $5.07 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $5.53 Million - $6.58 Million	29,500 Added 155.26%	48,500 $9.89 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $14 Million - $17.6 Million	-72,000 Reduced 79.12%	19,000 $4 Million
Q4 2021 Feb 15, 2022	BUY	$223.92 - $287.77 $4.48 Million - $5.76 Million	20,000 Added 28.17%	91,000 $21.8 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $1.41 Million - $1.85 Million	5,000 Added 7.58%	71,000 $20.1 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $777,000 - $1.24 Million	-3,000 Reduced 4.35%	66,000 $22.9 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $11.2 Million - $13.1 Million	-46,200 Reduced 40.1%	69,000 $19.3 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $13.8 Million - $20.7 Million	58,200 Added 102.11%	115,200 $28.2 Million
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $15.1 Million - $17.4 Million	57,000 New	57,000 $16.2 Million
Q1 2017 Jan 25, 2018	SELL	N/A	-5,000 Closed	0 $0
Q4 2016 Feb 23, 2018	BUY	N/A	4,950 Added 9900.0%	5,000 $1.31 Million
Q4 2016 Jan 24, 2018	BUY	N/A	50	50 $132,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.